The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hameed, A.
Right arrow Articles by Podack, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hameed, A.
Right arrow Articles by Podack, E. R.

The Journal of Immunology, Vol 141, Issue 9 3142-3147, Copyright © 1988 by American Association of Immunologists


ARTICLES

Characterization of three serine esterases isolated from human IL-2 activated killer cells

A Hameed, DM Lowrey, M Lichtenheld and ER Podack
Department of Microbiology and Immunology, University of Miami School of Medicine, FL 33101.

Human peripheral blood mononuclear cells, activated for 14 to 20 days with 1000 U/ml rIL-2, develop strong cytotoxicity for NK sensitive and resistant targets. This process is accompanied by the acquisition of cytoplasmic granules in approximately 60% of the cells and by the expression of esterase activity cleaving the synthetic substrate BLT. The esterase activity, localized in the cytoplasmic granules, was purified and characterized. Three proteins with 3H-DFP binding activity were isolated and had the following properties. Following the proposed nomenclature by Masson et al., the esterases were named human granzymes 1, 2, and 3. Human granzyme 1 on SDS-PAGE has an unreduced relative m.w. of 43,000 and can form disulfide-linked oligomers of relative higher m.w. All forms of granzyme 1 bind 3H-DFP. Upon reduction, granzyme 1 migrates with Mr 30,000 on SDS-PAGE. Additional proteolytic fragments of Mr 24,000 and Mr 28,000 are observed in some reduced preparations. Granzyme 1 cleaves the substrate BLT and appears homologous with murine granzyme A. Human granzyme 2 has an unreduced relative m.w. of 30,000; after reduction, it migrates at Mr 32,000. Even though granzyme 2 binds 3H-DFT, it does not cleave BLT. Human granzyme 2 has properties similar to those of murine granzymes B-H. Human granzyme 3 has unreduced and reduced relative m.w. of 25,000 and 28,000, respectively. It is active in cleaving the substrate BLT. A murine analog for human granzyme 3 has not been described previously. N- terminal sequencing of the purified human granzymes revealed that human granzyme 1 is the gene product of human Hanuka factor cDNA clone and that it represents the human homolog to murine granzyme A. Similarly, human granzyme 2 revealed absolute identity with cDNA-derived N- terminal sequence of a putative human lymphocyte protease cDNA clone.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. Zhao, H. Zhang, Y. Guo, and Z. Fan
Granzyme K Directly Processes Bid to Release Cytochrome c and Endonuclease G Leading to Mitochondria-dependent Cell Death
J. Biol. Chem., April 20, 2007; 282(16): 12104 - 12111.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
B. Bade, H. E. Boettcher, J. Lohrmann, C. Hink-Schauer, K. Bratke, D. E. Jenne, J. C. Virchow Jr, and W. Luttmann
Differential expression of the granzymes A, K and M and perforin in human peripheral blood lymphocytes
Int. Immunol., November 1, 2005; 17(11): 1419 - 1428.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. J. Fuller and A. J. Zajac
Ablation of CD8 and CD4 T Cell Responses by High Viral Loads
J. Immunol., January 1, 2003; 170(1): 477 - 486.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Hink-Schauer, E. Estebanez-Perpina, E. Wilharm, P. Fuentes-Prior, W. Klinkert, W. Bode, and D. E. Jenne
The 2.2-A Crystal Structure of Human Pro-granzyme K Reveals a Rigid Zymogen with Unusual Features
J. Biol. Chem., December 20, 2002; 277(52): 50923 - 50933.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
H. K. Ronday, W. H. van der Laan, P. P. Tak, J. A. D. M. de Roos, R. A. Bank, J. M. TeKoppele, C. J. Froelich, C. E. Hack, P. C. W. Hogendoorn, F. C. Breedveld, et al.
Human granzyme B mediates cartilage proteoglycan degradation and is expressed at the invasive front of the synovium in rheumatoid arthritis
Rheumatology, January 1, 2001; 40(1): 55 - 61.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Wilharm, M. A. A. Parry, R. Friebel, H. Tschesche, G. Matschiner, C. P. Sommerhoff, and D. E. Jenne
Generation of Catalytically Active Granzyme K from Escherichia coli Inclusion Bodies and Identification of Efficient Granzyme K Inhibitors in Human Plasma
J. Biol. Chem., September 17, 1999; 274(38): 27331 - 27337.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Rukavina, G. Laskarin, G. Rubesa, N. Strbo, I. Bedenicki, D. Manestar, M. Glavas, S. E. Christmas, and E. R. Podack
Age-Related Decline of Perforin Expression in Human Cytotoxic T Lymphocytes and Natural Killer Cells
Blood, October 1, 1998; 92(7): 2410 - 2420.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. A. Kummer, A. M. Kamp, F. Citarella, A. J. G. Horrevoets, and C. E. Hack
Expression of Human Recombinant Granzyme A Zymogen and Its Activation by the Cysteine Proteinase Cathepsin C
J. Biol. Chem., April 19, 1996; 271(16): 9281 - 9286.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1988 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1988 by The American Association of Immunologists, Inc. All rights reserved.